Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesBeginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Other financing activities (2019 - 2024)

Summit Therapeutics' Other financing activities history spans 5 years, with the latest figure at $1.2 million for Q4 2024.

  • For Q4 2024, Other financing activities changed N/A year-over-year to $1.2 million; the TTM value through Dec 2024 reached $1.2 million, up 92.25%, while the annual FY2023 figure was $619000.0, 1306.82% up from the prior year.
  • Other financing activities reached $1.2 million in Q4 2024 per SMMT's latest filing, up from $80000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $1.2 million in Q4 2024 to a low of -$67000.0 in Q4 2022.
  • Average Other financing activities over 4 years is $316833.3, with a median of $95500.0 recorded in 2022.
  • The largest YoY upside for Other financing activities was 85.59% in 2020 against a maximum downside of 85.59% in 2020.
  • A 4-year view of Other financing activities shows it stood at $48000.0 in 2020, then crashed by 239.58% to -$67000.0 in 2022, then soared by 219.4% to $80000.0 in 2023, then surged by 1387.5% to $1.2 million in 2024.
  • Per Business Quant, the three most recent readings for SMMT's Other financing activities are $1.2 million (Q4 2024), $80000.0 (Q2 2023), and $539000.0 (Q1 2023).